Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed
or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders
(The Pediatric MATCH Screening Trial)
How well does treatment that is directed by genetic testing work in pediatric patients
with solid tumors?
Basic Study Information
Purpose:Location: University of Rochester
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well
that is directed by genetic testing works in pediatric patients with solid tumors,
non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at
line of standard systemic therapy and/or for which no standard treatment exists that
shown to prolong survival. Genetic tests look at the unique genetic material (genes)
patients' tumor cells. Patients with genetic changes or abnormalities (mutations)
more from treatment which targets their tumor's particular genetic mutation, and may
doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Lead Researcher (Principal Investigator)
Lead Researcher: Angela Girvin
Study Contact Information
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search